US Patent 11608517 Antigen binding molecules and methods of use thereof
Patent 11608517 was granted and assigned to Kite Pharma, Inc. on March, 2023 by the United States Patent and Trademark Office.
All edits
Edits on 14 Aug, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Arianne Perez Garcia0
Jed Wiltzius0
Stuart Sievers0
Edits on 11 Apr, 2023
Golden AI
Edits made to:
Infobox (+15 properties)
Article (+372 characters)
US Patent 11608517 Antigen binding molecules and methods of use thereof
Article
Isolated antigen binding molecules that specifically binds to a molecule comprising an amino acid sequence selected from the group consisting of GSTSGSGKPGSGEGSTKG (SEQ ID NO: 1), GSGKPGSGEG (SEQ ID NO: 2), GKPGSGEG (SEQ ID NO: 3), SGKPGSGE (SEQ ID NO: 499) and KPGSG (SEQ ID NO: 500) are provided. The antigen binding molecules can be used in the methods provided herein.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
116085170
Date of Patent
March 21, 2023
0Patent Application Number
166677780
Date Filed
October 29, 2019
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11608517 Antigen binding molecules and methods of use thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
